phase 1_completion
saveInsignis Therapeutics Inc — HLK-0006 (Phase I Trial Completion)
community read0 votes
Therapy area: Immunology. Indication: Anaphylaxis, Food Allergy, Peanut Allergy
Therapy area: Immunology. Indication: Anaphylaxis, Food Allergy, Peanut Allergy